Dr. Majed A. Koleilat, MD

Dr. Koleilat practices at Deaconess Clinic I in Evansville, Indiana.

Dr. Koleilat's NPI, 1922175694, was assigned on November 29, 2006. Dr. Koleilat graduated from University Karlovy, Lek Fak Ii in 1996. Dr. Koleilat's Indiana license number on file is 01061301A.

Dr. Koleilat's primary practice is Deaconess Clinic I, at 6221 E Physicians Ct, Evansville, IN 47715 in Vanderburgh County. The practice phone is (812) 479-3153.

Dr. Koleilat's primary practice is Deaconess Clinic I in Evansville, Indiana. Dr. Koleilat is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Clinic. Dmand AI also links Dr. Koleilat to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koleilat practices, 6 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Koleilat's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Koleilat is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Koleilat's licenses on file in 2 states: Indiana and Pennsylvania.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Koleilat treats.

CMS data shows 6,505 Medicare services from Dr. Koleilat across 9 procedure codes in 2024, for 356 Medicare patients. Medicare paid $57,638 for them. Every service was in an office.

CMS counts 356 Medicare patients who saw Dr. Koleilat in 2024. The largest group is 65 to 74, with 212 patients. 74% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Koleilat's median patient age at 45, with 62% women.

In 2024, Dr. Koleilat wrote 1,712 Medicare Part D claims for 327 patients. 63% of them were for generic drugs. CMS names the drug for 1,564 of them, across 30 drugs with 11 or more claims each, at $415,956 in total drug cost. In 2023, CMS named 1,430 claims across 27 drugs.

Dr. Koleilat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koleilat as offering telehealth.

Dmand AI links 6 papers to Dr. Koleilat, published from 2010 to 2024. The most frequent topics are Angioedemas, Hereditary and Complement C1 Inhibitor Protein. Dr. Koleilat's most frequent co-authors are Timothy J. Craig, DO, Roger A. Friedman, MD and Bruce L. Zuraw, MD.

Dmand AI links Dr. Koleilat to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Asthma, Aspirin-Induced and Hereditary Complement Deficiency Diseases.

CMS Open Payments shows 1,079 general payments to Dr. Koleilat from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $100,190. It also lists 1 research payment totaling $735 in 2017.

Dmand AI lists 2 awards for Dr. Koleilat, most recently CMS Stage 1 EHR in 2013.

Dr. Koleilat graduated from University Karlovy, Lek Fak Ii in 1996. Dr. Koleilat is a member of AAAAI.

Dr. Koleilat is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.